October 28, 2020
FDA Approves Veklury for Treatment of COVID-19 Patients Who Meet Certain Criteria
The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.